- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (1688)
- Timeline of Article Publication (11)
- Authors Evaluation (3)
- Article Quality Tracking (1)
- Reference Citation Analysis (2)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2057)
All Articles published online
|
Publishing Process of This Article
|
Jan 15, 2024 (publication date) through Feb 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li BB, Chen LJ, Lu SL, Lei B, Yu GL, Yu SP. C-reactive protein to albumin ratio predict responses to programmed cell death-1 inhibitors in hepatocellular carcinoma patients. World J Gastrointest Oncol 2024; 16(1): 61-78 [PMID: 38292845 DOI: 10.4251/wjgo.v16.i1.61] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i1/61.htm |
| Number | Citing Articles |
| 1 |
Zhengzheng Ji, Jiasong Li, Shasha Zhang, Yuanyuan Jia, Jing Zhang, Zhanjun Guo. The load of hepatitis B virus reduces the immune checkpoint inhibitors efficiency in hepatocellular carcinoma patients. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1480520
|
| 2 |
Xiaoyu Huang, Gang Peng, Yaqing Kong, Xiaojing Cao, Xiang Zhou. The Prognostic Value of CRP/Alb Ratio in Predicting Overall Survival for Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Combined with Molecular-Targeted Agents and PD-1/PD-L1 Inhibitors. Journal of Inflammation Research 2025; : 203 doi: 10.2147/JIR.S483208
|
| 3 |
Zhengzheng Ji, Ding Fang, Jiasong Li, Ruijie Cao, Handong Wang, Zesong Meng, Zhanjun Guo, Yue Zhao. Serum Alpha-fetoprotein Associated with Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma: A Meta-Analysis and a Retrospective Cohort Study. Hepatitis Monthly 2025; 24(1) doi: 10.5812/hepatmon-145022
|
| 4 |
Jun-Ming Zhu, Shao-Hao Chen, Yi-Cheng Xu, Rui-Cheng Gao, Hai Cai, Qing-Shui Zheng, Xiong-Lin Sun, Xue-Yi Xue, Yong Wei, Ning Xu. ALB inhibits tumor cell proliferation and invasion by regulating immune microenvironment and endoplasmic reticulum stress in clear cell renal cell carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025; 1871(3): 167672 doi: 10.1016/j.bbadis.2025.167672
|